Picture of BioPorto A/S logo

BIOPOR BioPorto A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Bioporto Q1 EBIT Loss Narrows To DKK 16.4 Mln

May 7 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * REG-BIOPORTO ANNOUNCES Q1 2020 REPORT
    * Q1  REVENUE DKK 4.2 MILLION VERSUS DKK 5.5 MILLION YEAR
AGO
    * Q1 EBIT LOSS DKK 16.4 MILLION VERSUS LOSS DKK 17.1 
MILLION YEAR
AGO
    * 2020 GUIDANCE MAINTAINED
    * TIMELINE FOR FDA APPLICATION FOR NGAL TEST: BIOPORTO
PROJECTS
THAT COSTS RELATED TO CLINICAL TRIAL AS WELL AS SUBMISSION OF
FDA APPLICATION WILL BE POSTPONED TO SECOND HALF OF 2020.

Source text for Eikon:  ID:nGNE62fXy5 
Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on BioPorto A/S

See all news